SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001520138-16-001180
Filing Date
2016-09-28
Accepted
2016-09-28 17:30:06
Documents
40
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD ENDED JUNE 30, 2016 bivi-20160630_10k.htm 10-K 463552
2 EXHIBIT 31.1 bivi-20160630_10kex31z1.htm EX-31.1 12503
3 EXHIBIT 32.1 bivi-20160630_10kex32z1.htm EX-32.1 6190
4 GRAPHIC image_001.jpg GRAPHIC 30009
5 GRAPHIC image_002.jpg GRAPHIC 2788
  Complete submission text file 0001520138-16-001180.txt   1565386

Data Files

Seq Description Document Type Size
6 XBRL DEFINITION FILE bivi-20160630_def.xml EX-101.DEF 24245
7 XBRL LABEL FILE bivi-20160630_lab.xml EX-101.LAB 118777
8 XBRL PRESENTATION FILE bivi-20160630_pre.xml EX-101.PRE 87933
9 XBRL SCHEMA FILE bivi-20160630.xsd EX-101.SCH 15932
10 XBRL INSTANCE FILE bivi-20160630.xml EX-101.INS 183797
11 XBRL CALCULATION FILE bivi-20160630_cal.xml EX-101.CAL 19681
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-55292 | Film No.: 161907858
SIC: 2834 Pharmaceutical Preparations